pH-sensitive paramagnetic liposomes as MRI contrast agents: in vitro feasibility studies.

A novel type of pH-sensitive paramagnetic contrast agent is introduced; a low molecular weight gadolinium (Gd) chelate (GdDTPA-BMA) encapsulated within pH-sensitive liposomes. The in vitro relaxometric properties of the liposomal Gd chelate were shown to be a function of the pH in the liposomal dispersion and the membrane composition. Only a minor pH-dependency of the T1 relaxivity (r1) was observed for liposomal GdDTPA-BMA composed of the unsaturated lipids dioleoyl phosphatidyl ethanolamine (DOPE) and oleic acid (OA). On the other hand, the r1 of GdDTPA-BMA encapsulated within saturated dipalmitoyl phosphatidyl ethanolamine/palmitic acid (DPPE/PA) liposomes demonstrated a strong pH-dependency. At physiological pH and above, the r1 of this system was significantly lowered compared to that of non-liposomal Gd chelate, which was explained by an exchange limited relaxation process. Lowering the pH below physiological value, however, gave a sharp and 6-7 fold increase in r1, due to liposome destabilisation and subsequent leakage of entrapped GdDTPA-BMA. The pH-sensitivity of the DPPE/PA liposome system was confirmed in an in vitro magnetic resonance imaging (MRI) phantom study.

Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: in vitro feasibility studies.

RATIONALE AND OBJECTIVES: Magnetic resonance (MR) imaging-based temperature monitoring has gained interest for use in general hyperthermia treatment of tumors. Such therapy requires an accurate control of the temperature, which should range from 41 degrees to 45 degrees C. A novel type of thermosensitive MR agent is proposed: liposome-encapsulated gadolinium chelates whose temperature response is linked to the phase-transition properties of the liposome carrier. In vitro relaxometry and MR imaging were used to evaluate the thermosensitivity of the contrast properties of liposomal gadolinium diethylenetriaminepentaacetic acid bis(methylamide) (Gd-DTPA-BMA). MATERIALS AND METHODS: T1 relaxivity (rl) measurements of liposomal Gd-DTPA-BMA were undertaken at 0.47 T and at temperatures of 20 degrees-48 degrees C. MR imaging was performed at 2.0 T with a gel phantom containing inserts of liposomes. Diffusion-weighted and T1-weighted gradient-recalled echo images were acquired as the phantom was heated from 22 degrees to about 65 degrees C. RESULTS: At ambient temperature, the r1 of liposomal Gd-DTPA-BMA was exchange limited due to slow water exchange between the liposome interior and exterior. A sharp, marked increase in r1 occurred as the temperature reached and exceeded the gel-to-liquid crystalline phase-transition temperature (Tm) of the liposomes (42 degrees C). The relaxation enhancement was mainly attributable to the marked increase in transmembrane water permeability, yielding fast exchange conditions. There was good correlation between the relaxometric and imaging results; the signal intensity on T1-weighted gradient-recalled echo images increased markedly as the temperature approached Tm. The temperature sensitivity of the diffusion-weighted technique differed from that of the liposome-based T1-weighted approach, with an apparent water diffusion coefficient increasing linearly with temperature. CONCLUSION: Since the transition from low to high signal intensity occurred in the temperature range of 38 degrees - 42 degrees C, the investigated paramagnetic liposomes have a potential role as "off-on" switches for temperature control during hyperthermia treatment.

NMRD investigation of DyDTPA- and GdDTPA-labeled starch particles. Selection of a suitable suspension medium and influence of the starch matrix on relaxivity.

RATIONALE AND OBJECTIVES: The primary aim was to investigate the influence of the starch matrix on the T1 relaxivities of starch particles labeled with gadolinium and dysprosium diethylenetriamine pentaacetic acid (GdDTPA-SP and DyDTPA-SP). Achieving this required the selection of a medium that was suitable for suspending the particles and that had field-independent T1 relaxation rates, thereby eliminating errors in relaxivity determinations resulting from a field-dependent background. METHODS: GdDTPA-SP with low and high gadolinium content, DyDTPA-SP, and empty DTPA-SP were suspended in an aqueous medium containing 5% (w/w) of a polyethylene glycol-based block copolymer. 1/T1 NMRD profiles were obtained in the temperature range of 5 degrees to 35 degrees C. RESULTS: Using the block copolymer, particles did not settle, and samples could be prepared at a low temperature to avoid particle degradation, the intrinsic T1 relaxation rate of the suspension medium was field-independent and identical to that of water from 25 degrees to 35 degrees C. The T1 relaxivities of DyDTPA-SP were higher than those of dysprosium diethylenetriamine pentaacetate-bis(methylamide) (DyDTPA-BMA) and decreased with increasing magnetic field strength. The T1 relaxivity of GdDTPA-SP was higher than that of GdDTPA at all fields, and decreased with decreasing temperature and increasing gadolinium content. CONCLUSIONS: The GdDTPA-SP results showed that the particulate starch matrix served a dual role, with opposing influences on relaxivity. It provided a means for increasing the rotational correlation time (tau R), which resulted in higher relaxivities. However, it also retarded radial diffusion of water molecules within the particle interior, which significantly counteracted the enhancing effect of tau R. For DyDTPA-SP, the starch matrix provided an additional diamagnetic contribution, resulting in relaxivities higher than those of DyDTPA-BMA. The block copolymer was suitable as a suspension medium for DyDTPA-SP and GdDTPA-SP and should also be applicable for other particulates.

Investigation of lanthanide-based starch particles as a model system for liver contrast agents.

Gadolinium and dysprosium diethylenetriamine pentaacetic acid-labeled starch microparticles (Gd-DTPA-SP and Dy-DTPA-SP) were investigated as model liver contrast agents. The liver contrast efficacy of particles with low and high metal contents was compared in two imaging models: in vivo rat liver and ex vivo perfused rat liver. The biodistribution of intravenously injected particles was also assessed by ex vivo relaxometry and inductively coupled plasma atomic emission spectrophotometry of tissues. All particles reduced the liver signal intensity on T2-weighted spin-echo and gradient-recalled echo images as a result of susceptibility effects. Because of their higher magnetic susceptibility, the Dy-DTPA-SP were more effective negative contrast enhancers than the Gd-DTPA-SP. On T1-weighted spin-echo images, only the Gd-DTPA-SP with low metal content significantly increased the liver signal intensity. In addition, these low-loading Gd-DTPA-SP markedly reduced the blood T1. The two latter observations were not consistent with the anticipated blood circulation time of microparticles, but were a result of the lower stability of these particles in blood compared with Gd-DTPA-SP, which has a high metal content. Regardless of stability or imaging conditions, the paramagnetic starch particles investigated showed potential as negative liver contrast enhancers. However, the observed accumulation of particles in the lungs represented a biological limitation for their use as contrast agents.

Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity.

The in vitro contrast efficacy of liposome encapsulated gadolinium-[10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1, 4,7-triacetic acid] (GdHPDO3A) has been assessed by relaxometry. The internal concentrations were 150 and 250 mM Gd. Two types of liposome compositions were investigated: a phospholipid blend consisting of both hydrogenated phosphatidylcholine (HPC) and phosphatidylserine (HPS) with a gel-to-liquid crystalline phase transition temperature (Tm) of 50 degrees C, and a mixture of dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylglycerol (DPPG) with a Tm of 41 degrees C. The investigated liposome size range was 70-400 nm. The T1 and T2 relaxivities (r1 and r2) of liposome encapsulated GdHPDO3A were significantly reduced at 37 degrees C and 0.47 T, compared to those of non-liposomal metal chelate, due to an exchange limitation of the dipolar relaxation process. The highest relaxivity values were obtained for the DPPC/DPPG liposomes, and were attributed to a higher liposome water permeability and to a more efficient water exchange across the membrane. A reduction in liposome size increased the r1, confirming the exchange limited dipolar relaxation. The increased r1 with increasing temperature demonstrated the prerequisite of rapid water exchange between the interior and exterior of the liposome for efficient dipolar relaxation enhancement. Susceptibility effects were present in the liposome systems as the r2/r1 ratio increased with increasing liposome size and internal Gd concentration. In summary, the current work has shown the influence of key physicochemical properties, such as liposome size, membrane composition and permeability, on the in vitro relaxivity of liposome encapsulated GdHPDO3A.

Paramagnetic liposomes as magnetic resonance imaging contrast agents. Assessment of contrast efficacy in various liver models.

RATIONALE AND OBJECTIVES: Liposomal gadolinium (Gd)-HP-DO3A has been evaluated as a contrast agent for liver magnetic resonance imaging. The influence of various liposomal physicochemical properties on the liver uptake and contrast efficacy was investigated in various ex vivo and in vivo liver models. METHODS: Liposomes of different size and membrane properties were prepared. The liposome size ranged from 74 to 304 nm. Two types of phospholipid compositions were studied; a mixture of hydrogenated phosphatidylcholine (HPC) and hydrogenated phosphatidylserine (HPS) with a phase transition temperature (Tm) of 51 degrees C and, a blend composed of dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylglycerol (DPPG) displaying a Tm of 41 degrees C. Ex vivo tissue relaxometry and in vivo liver imaging were used to study the influence of liposome composition on the liver uptake and contrast efficacy of intravenously injected liposomes. The influence of liposome size and composition on the kinetics of liver uptake and imaging effect was assessed ex vivo in the perfused rat liver. RESULTS: The HPC/HPS preparations showed generally a higher and faster liver uptake than the DPPC/DPPG preparations due to a higher stability in blood/perfusate (high Tm) and to the HPS component. The liposome size modulated the extent and kinetics of liver uptake; the larger the size, the faster and more extensive was the liver uptake. Both types of liposome preparations were shown to be efficient liver susceptibility agents both ex vivo and in vivo due to their uptake by the Kupffer cells of liver. The lack of full correlation between the extent of liver uptake and degree of contrast enhancement might be attributed to different regimes of susceptibility-based relaxation. CONCLUSIONS: The present study has demonstrated the influence of key liposomal physicochemical properties on the liver uptake and contrast efficacy of liposome-encapsulated Gd chelates, exemplified by Gd-HP-DO3A.

Magnetic field dependence of solvent proton relaxation by solute dysprosium (III) complexes.

RATIONALE AND OBJECTIVES: Many magnetic resonance imaging (MRI) agents are Gd(III)-based; its half-filled f-shell has an S-ground state and hence a long electronic relaxation time, leading to comparably large effects on 1/T1 and 1/T2 of water protons with no shift in the water-proton resonance frequency. 1/T1 and 1/T2 nuclear magnetic relaxation dispersion (NMRD) profiles of the Dy(III) aquo ion and its chelates have been reported recently. Dy(III) ions differ magnetically from Gd(III); the large spin-orbit interaction of its non-S-ground state reduces the electronic relaxation time 100-fold, and can have a large effect on proton 1/T2 and resonance frequency. Relaxation theory is well-developed and applicable to both ions but, for Dy(III), the phenomena are more wide-ranging. Recent interpretations have suggested that the data are anomolous, requiring a new mechanism for their explanation. The authors explain published Dy(III) data in terms of known theory, guided by experience with Gd(III) agents. METHODS: For fields below 1 T, the authors incorporate the shortened electronic relaxation time into the usual low-field theory for magnetic dipolar interactions between water protons and Dy(III) magnetic moments. Both inner- and outer-sphere relaxations are included. At higher fields (and unusual for small single-ion agents) one must include dipolar interactions of protons with the magnetization of the Dy(III) moments. This "Curie magnetization" causes a quadratic dependence of 1/T1 on field, and--through dipolar-induced shifts--an even greater quadratic dependence of 1/T2. RESULTS: All published data can be explained by magnetic dipolar interactions. For Dy(III), the Curie term has a longer correlation time than the low-field term, namely, the rotation of solute for 1/T1 and the even longer water exchange lifetime tau M for 1/T2. This exchange modulates the shift, producing phenomena not seen with Gd(III). CONCLUSIONS: Relaxation by Dy(III) chelates can be explained by the same well-established theory of dipolar interactions used for their Gd(III) analogs. Interestingly, for MRI applications, tau M should be long for Dy(III)-based agents and short for Gd(III)-based agents.